Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/26/2012WO2012054718A2 Treating long qt syndrome
04/26/2012WO2012054716A1 Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
04/26/2012WO2012054701A2 Creatine oral supplementation using creatine hydrochloride salt
04/26/2012WO2012054698A1 Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
04/26/2012WO2012054695A1 Ntimicrobial amphiphiles and methods for their use
04/26/2012WO2012054566A2 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain
04/26/2012WO2012054535A2 Compounds, compositions and methods useful for cholesterol mobilisation
04/26/2012WO2012054530A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054528A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054527A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054526A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054523A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054521A2 Antimicrobial polyether and polyol compounds
04/26/2012WO2012054510A1 Oxadiazole compounds which inhibit beta-secretase activity and methods of use thereof
04/26/2012WO2012054493A1 Deuterated serine-threonine protein kinase modulators
04/26/2012WO2012054447A2 Use of storage stable viscous phospholipid depot to treat wounds
04/26/2012WO2012054446A2 Combination therapy
04/26/2012WO2012054417A1 Amide derivatives of benzene-sulfonanilide, pharmaceutical composition thereof and method for cancer treatment using the same
04/26/2012WO2012054408A2 Bioavailability enhancement delivery system
04/26/2012WO2012054393A2 Bioavailability enhancement delivery system
04/26/2012WO2012054388A1 Tph1 inhibitors and bisphosphonates for preventing and treating low bone mass diseases
04/26/2012WO2012054367A1 Rho kinase inhibitors
04/26/2012WO2012054366A2 Substituted amino-triazolyl pde10 inhibitors
04/26/2012WO2012054364A2 Bicyclic diamines as janus kinase inhibitors
04/26/2012WO2012054334A1 Method of treating herpes virus infection using macrocyclic lactone compound
04/26/2012WO2012054333A2 Methods for identifying inhibitors of abeta42 oligomers
04/26/2012WO2012054332A1 Substituted hydroxamic acids and uses thereof
04/26/2012WO2012054331A1 Method of treating otitis externa using macrocyclic lactone compound
04/26/2012WO2012054328A1 Method of treating hemorrhoids using macrocyclic lactone compound
04/26/2012WO2012054315A1 Cathepsin s inhibitor compounds
04/26/2012WO2012054233A1 Nematocidal sulfonamides
04/26/2012WO2012054228A1 Compounds and methods for the prevention and treatment of cancer
04/26/2012WO2012054110A2 Compounds and methods for inhibiting phosphate transport
04/26/2012WO2012054093A2 Acyl piperidine inhibitors of soluble epoxide hydrolase
04/26/2012WO2012054092A1 Lipid cofactors for facilitating propogation of prpsc
04/26/2012WO2012054090A1 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
04/26/2012WO2012053942A1 Solutions for bicarbonate hemodialysis
04/26/2012WO2012053787A2 Aryloxy phenoxy acrylic compound having hif-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient
04/26/2012WO2012053785A2 Sustained-release pellets containing tacrolimus as an active ingredient
04/26/2012WO2012053768A2 Aryloxyphenoxyacetyl-based compound having hif-1 inhibition activity, preparation method thereof and pharmaceutical composition containing the same as an active ingredient
04/26/2012WO2012053758A2 Pharmaceutical composition for treating or preventing alcoholic liver diseases, containing cilostazol as active ingredient
04/26/2012WO2012053741A2 Nucleic acid molecules inducing rna interference, and uses thereof
04/26/2012WO2012053727A1 Composition including nicotinamide as an active ingredient for preventing or treating alkylating agent-induced apoptotic neurodegeneration
04/26/2012WO2012053654A1 Sustained-release formulation for injection
04/26/2012WO2012053630A1 Antagonist for mutated androgen receptor
04/26/2012WO2012053606A1 Arylaminoheterocyclic carboxamide compound
04/26/2012WO2012053408A1 Anti-leishmania compound and anti-leishmania drug
04/26/2012WO2012053232A1 Anti-leishmania compound and anti-leishmania drug
04/26/2012WO2012053186A1 Arylamide derivatives as ttx-s blockers
04/26/2012WO2012053016A1 Sustained release pharmaceutical compositions of donepezil
04/26/2012WO2012053014A2 Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
04/26/2012WO2012053012A2 Topical pharmaceutical compositions comprising tfflocolchicoside
04/26/2012WO2012053011A2 Ophthalmic compositions comprising brinzolamide
04/26/2012WO2012053010A2 Method for treatment of acne using pharmaceutical compositions of clindamycin
04/26/2012WO2012053008A1 Topical pharmaceutical compositions comprising etodolac
04/26/2012WO2012053007A1 Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
04/26/2012WO2012053003A1 A novel herbal oil for controlling blood sugar without risk of hypoglycemea
04/26/2012WO2012052956A1 Methods and compositions for treating pox virus infections with an 1, 4 -naphthoquinone as active agent
04/26/2012WO2012052953A1 MiRNA
04/26/2012WO2012052948A1 Pyridine- 2- derivatives as smoothened receptor modulators
04/26/2012WO2012052918A1 Use of mexiprostil in the treatment of inflammatory bowel disease and/or of irritable bowel syndrome
04/26/2012WO2012052888A1 Sodium 2 -mercaptoethane sulfonate for use in the treatment of lumbar pain
04/26/2012WO2012052843A1 Pochoxime conjugates useful for the treatment of hsp90 related pathologies
04/26/2012WO2012052753A1 Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors
04/26/2012WO2012052745A1 Combinations of pi3k inhibitors with a second anti -tumor agent
04/26/2012WO2012052730A1 Use of pi3k inibitors for the treatment of obesity, steatosis and ageing
04/26/2012WO2012052668A1 Novel benzothiophene derivatives with tnap-inhibiting activity
04/26/2012WO2012052595A1 Bicyclic aminocyclitols and use thereof for the treatment of lysosomal diseases
04/26/2012WO2012052563A1 Compositions comprising a filler product and a compound of the tetracycline family used at a subantimicrobial dose
04/26/2012WO2012052562A1 Compositions comprising a filler product and a chemically modified tetracycline
04/26/2012WO2012052556A1 Novel haloalkoxyquinazolines, and preparation and use thereof
04/26/2012WO2012052555A1 Formulation comprising arginine, use and preparation thereof
04/26/2012WO2012052540A1 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
04/26/2012WO2012052491A2 1-(heterocyclic carbonyl)-2-substituted pyrrolidines
04/26/2012WO2012052479A2 Brimonidine gel compositions and methods of use
04/26/2012WO2012052472A1 Pharmaceutical topical composition of mupirocin
04/26/2012WO2012052463A1 Cysteine and food intake
04/26/2012WO2012052459A1 Pyrazole compounds acting against allergic, inflammatory and immune disorders
04/26/2012WO2012052458A1 Pyrazole compounds acting against allergic, immune and inflammatory conditions
04/26/2012WO2012052451A1 Metabotropic glutamate receptor modulators
04/26/2012WO2012052444A1 Process for the preparation of nicotinamide derivatives
04/26/2012WO2012052395A1 Isoxazole derivatives used as oestrogen modulators
04/26/2012WO2012052390A1 N-2-(2-pyridinyl)-4-pyrimidinyl-beta-alanine derivatives as inhibitors of histone demethylase jmjd3
04/26/2012WO2012052372A1 Tetrahydroquinoline derivatives used as ampk activators
04/26/2012WO2012052297A1 Carbonate derivatives for the treatment of cough
04/26/2012WO2012052180A1 Combinations comprising dhodh inhibitors and cox inhibitors
04/26/2012WO2012052179A1 Amino derivatives for the treatment of proliferative skin disorders
04/26/2012WO2012052169A2 Particulate pharmaceutical composition containing an opioid and an opioid antagonist
04/26/2012WO2012052167A1 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
04/26/2012WO2012052102A1 Quinoxaline derivates
04/26/2012WO2012052097A1 Method for producing a cosmetic agent
04/26/2012WO2012051941A1 Uses of 15-benzylidene-14-deoxy-11,12-dehydroandrographolide derivatives in the preparation of antineoplastic drugs
04/26/2012WO2012051926A1 Compound molecule, preparation method and pharmaceutical compositions thereof
04/26/2012WO2012051912A1 Nitrogen-containing biphenyl compounds, pharmaceutical compositions of same, preparation methods and anti-hiv-1 uses thereof
04/26/2012WO2012051708A1 Anti-bacterial pyruvate kinase modulator compounds, compositions, uses, and methods
04/26/2012WO2012051707A1 Methods for the prevention and/or treatment of memory impairment
04/26/2012WO2012051692A1 Processes for the preparation of rivaroxaban and intermediates thereof
04/26/2012WO2012051663A1 Antimicrobial compounds
04/26/2012WO2012051659A1 Viral polymerase inhibitors
04/26/2012WO2012032337A3 A transdermal drug administration device
1 ... 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 ... 7860